OTC · ASNB
EKIMAS Corporation
Financial Services · Shell Companies
$0.85
Up+$0.05 (+6.58%)
Updated Aug 16, 2026, 5:54 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.83M
- P/E ratio
- -16.19
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 4.53K
- Avg. volume
- 2.02K
Price performance
ASNB price history
1M range · 0 trading sessions · Daily adjusted prices
ASNB does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ASNB news
The latest Smart Investors Daily articles mentioning ASNB.
Stock researchCompany · Overview
ASNB research
Overview
Company profile and research snapshot.
Company profile
EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
